Clarus Company Profile

What is the competitive landscape for CLARUS, and when can generic versions of CLARUS drugs launch?

CLARUS has one approved drug.

There are seven US patents protecting CLARUS drugs.

There are twenty-four patent family members on CLARUS drugs in nine countries.

Summary for Clarus

International Patents:	24
US Patents:	7
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Clarus

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-002	Mar 27, 2019		RX	Yes	No	11,179,403
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-002	Mar 27, 2019		RX	Yes	No
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-001	Mar 27, 2019		RX	Yes	No	8,778,916		Y
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-003	Mar 27, 2019		RX	Yes	Yes	10,617,696		Y	Y
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-002	Mar 27, 2019		RX	Yes	No	10,617,696		Y	Y
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-002	Mar 27, 2019		RX	Yes	No	8,241,664		Y
Clarus	JATENZO	testosterone undecanoate	CAPSULE;ORAL	206089-003	Mar 27, 2019		RX	Yes	Yes	8,241,664		Y

International Patents for Clarus Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	2979699
Japan	2016074677
Brazil	PI0607549
South Korea	20080009201
Japan	2013121986
China	101217963
Japan	5778705

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Clarus